8-K current report · filed Nov 2, 2026

AbbVie Inc (ABBV) 8-K Current Report: November 2, 2026

Item 5.02ABBV overview

Short answer

AbbVie Inc (ABBV) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Jennifer L. Davis resigning as Class II director effective November 2, 2026.

AbbVie Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Jennifer L. Davis resigning as Class II director effective November 2, 2026
  • Departure follows her appointment as Align Technology CEO
  • No dispute or disagreement with AbbVie cited
  • Board vacancy and potential succession or committee reassignment implications for shareholders

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other AbbVie Inc 8-K filings

Get the next ABBV 8-K as it lands

Follow ABBV for push alerts, or ask the research agent what this filing means.